Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Johnson and Johnson: New HIV tests approved

Johnson and Johnson: New HIV tests approved

31st March 2008

A new diagnostic test has been approved for the detection of antibodies to Human Immunodeficiency Virus Types 1 and 2 (anti-HIV-1 and anti-HIV-2), it has emerged.

The US Food and Drug Administration granted approval for Ortho-Clinical Diagnostics to conduct the assay, which will be run on the group’s VITROS ECi/ECiQ Immunodiagnostic system.

It is thought that tests run through this system will be able to achieve results in under 50 minutes and can be carried out in the United States, Puerto Rico and other American territories.

According to Johnson & Johnson, the testing system may make anti-HIV-1 and anti-HIV-2 tests more effective, with random access and automation features helping to increase the efficiency and productivity of laboratories.

The firm stated that new research from teams sponsored by the National Institute of Health and the National Institute on Drug Abuse has claimed that with the development of computer models, the cost of routine screening for HIV in health care settings could be as cost effective as similar screening processes for breast cancer and high blood pressure.

According to Aids and HIV-awareness charity Avert, at the end of 2006, there were around 73,000 people with HIV in the UK – although one-third of these may be unaware that they are infected.

We currently have 7 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.